ScholarIQanswers from OpenAlex & ORCID
Joachim G.J.V. Aerts
ResearcherPublications, citations & collaboration network
Joachim G.J.V. Aerts is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Joachim G.J.V. Aerts have?
ScholarIQindexed works
Joachim G.J.V. Aerts has 688 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Joachim G.J.V. Aerts have?
ScholarIQcitation count
Joachim G.J.V. Aerts has 31,526 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Joachim G.J.V. Aerts?
ScholarIQh-index
Joachim G.J.V. Aerts has an h-index of 71 in OpenAlex.
What is the i10-index of Joachim G.J.V. Aerts?
ScholarIQi10-index
Joachim G.J.V. Aerts has an i10-index of 264 in OpenAlex.
What is the ORCID of Joachim G.J.V. Aerts?
ScholarIQorcid
The ORCID for Joachim G.J.V. Aerts is on the source record.
What is the OpenAlex record for Joachim G.J.V. Aerts?
ScholarIQopenalex
The OpenAlex for Joachim G.J.V. Aerts is on the source record.
What are the most-cited papers on Joachim G.J.V. Aerts?
ScholarIQmost cited works
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Paul Baas, Lucio Crinò, Wilfried Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Płużański, Everett E. Vokes, Esther Holgado, David Waterhouse, Neal Ready, Justin F. Gainor, Osvaldo Arén Frontera, Libor Havel, Martin Steins, Marina Chiara Garassino, Joachim G.J.V. Aerts, Manuel Dómine, Luis Paz‐Ares, Martin Reck, Christine Baudelet, Christopher Harbison, Brian Lestini, David R. Spigel
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
Global Burden of Disease Long COVID Collaborators, Sarah Wulf Hanson, Cristiana Abbafati, Joachim G.J.V. Aerts, Ziyad Al‐Aly, Charlie Ashbaugh, Tala Ballouz, Oleg Blyuss, Polina Bobkova, Gouke J. Bonsel, С. Н. Борзакова, Danilo Buonsenso, Denis Butnaru, Austin Carter, Helen Y. Chu, Cristina De Rose, Mohamed Mustafa Diab, Emil Ekbom, Maha El Tantawi, Victor Fomin, Robert Frithiof, Aysylu Gamirova, Petr Glybochko, Juanita A. Haagsma, Shaghayegh Haghjooy Javanmard, Erin B Hamilton, Gabrielle Harris, Majanka H. Heijenbrok‐Kal, Raimund Helbok, Merel E. Hellemons, David Hillus, Susanne M. Huijts, Michael Hultström, Waasila Jassat, Florian Kurth, Ing‐Marie Larsson, Miklós Lipcsey, Chelsea Liu, Callan Loflin, Andreï Malinovschi, Wenhui Mao, Lyudmila Mazankova, Denise J. McCulloch, Dominik Menges, Noushin Mohammadifard, Daniel Munblit, Nikita Nekliudov, Osondu Ogbuoji, И. М. Османов, José L. Peñalvo, Maria Skaalum Petersen, Milo A. Puhan, Md Mujibur Rahman, Verena Rass, Nickolas Reinig, Gerard M. Ribbers, Antonia Ricchiuto, Sten Rubertsson, Э. Р. Самитова, Nizal Sarrafzadegan, Anastasia Shikhaleva, Kyle E Simpson, Dario Sinatti, Joan B. Soriano, Ekaterina Spiridonova, Fridolin Steinbeis, Andrey А. Svistunov, Piero Valentini, Brittney van de Water, Rita J. G. van den Berg-Emons, Ewa Wallin, Martin Witzenrath, Yifan Wu, Hanzhang Xu, Thomas Zöller, Christopher Adolph, James Albright, Joanne O Amlag, Aleksandr Y. Aravkin, Bree Bang-Jensen, Catherine Bisignano, Rachel Castellano, Emma Castro, Suman Chakrabarti, James K. Collins, Xiaochen Dai, Farah Daoud, Carolyn Dapper, Amanda Deen, Bruce Bartholow Duncan, Megan Erickson, Samuel B Ewald, Alize J Ferrari, Abraham D. Flaxman, Nancy Fullman, Amiran Gamkrelidze, J Giles, Gaorui Guo, Simon I Hay, Jiawei He
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder, Melanie Lukkes, Larissa Klaase, Thierry van den Bosch, Menno van Nimwegen, Sai Ping Lau, Kitty Latupeirissa, Sjoerd Schetters, Yvette van Kooyk, Louis Boon, Antien Moyaart, Yvonne M. Mueller, Peter D. Katsikis, Alexander M.M. Eggermont, Heleen Vroman, Ralph Stadhouders, Rudi W. Hendriks, Jan H. von der Thüsen, Dirk J. Grünhagen, Cornelis Verhoef, Thorbald van Hall, Joachim G.J.V. Aerts
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Martin Reck, Alexander Luft, Aleksandra Szczęsna, Libor Havel, Sang-We Kim, Wallace Akerley, M. Catherine Pietanza, Yi‐Long Wu, Christoph Zielinski, Michael J. Thomas, Enriqueta Felip, Kathryn A. Gold, Leora Horn, Joachim G.J.V. Aerts, Kazuhiko Nakagawa, Paul Lorigan, Anne Pieters, Teresa Kong Sanchez, Justin Fairchild, David R. Spigel
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
Naoyuki Nogami, Fabrice Barlési, Mark A. Socinski, Martin Reck, Christian A. Thomas, Federico Cappuzzo, Tony Mok, Gene Grant Finley, Joachim G.J.V. Aerts, Francesco Orlandi, Denis Moro‐Sibilot, Robert M. Jotte, Daniil Stroyakovskiy, Liza C. Villaruz, Delvys Rodríguez‐Abreu, Wan‐Teck Lim, David M. Merritt, Shelley Coleman, Anthony Lee, Geetha Shankar, Wei Yu, Ilze Bāra, Makoto Nishio